Literature DB >> 16258871

In vitro assessment of the host response against Enterococcus faecalis used in probiotic preparations.

A Kropec1, M Hufnagel, K Zimmermann, J Huebner.   

Abstract

Along with other lactic acid bacteria, enterococci are used in food products and as health promoting agents. The safety of these products must be ensured, because they contain potentially pathogenic microorganisms. Here we present an in vitro opsonophagocytic assay that closely mimics the protective human immune response to Enterococcus faecalis and Enterococcus faecium. A collection of closely related E. faecalis isolates used as probiotics showed different susceptibilities to opsonic killing, suggesting that some of these isolates possess a capsule while other do not. This information may be helpful in assessing the safety of a given bacterial isolate used and could detect likely enterococcal candidates for probiotic preparations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16258871     DOI: 10.1007/s15010-005-5063-7

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  4 in total

1.  The short form of TSLP is constitutively translated in human keratinocytes and has characteristics of an antimicrobial peptide.

Authors:  L Bjerkan; O Schreurs; S A Engen; F L Jahnsen; E S Baekkevold; I J S Blix; K Schenck
Journal:  Mucosal Immunol       Date:  2014-05-21       Impact factor: 7.313

2.  Functional and safety aspects of enterococci in dairy foods.

Authors:  Arun Bhardwaj; R K Malik; Prashant Chauhan
Journal:  Indian J Microbiol       Date:  2009-03-25       Impact factor: 2.461

3.  Lytic Bacteriophage EFA1 Modulates HCT116 Colon Cancer Cell Growth and Upregulates ROS Production in an Enterococcus faecalis Co-culture System.

Authors:  Mwila Kabwe; Terri Meehan-Andrews; Heng Ku; Steve Petrovski; Steven Batinovic; Hiu Tat Chan; Joseph Tucci
Journal:  Front Microbiol       Date:  2021-03-31       Impact factor: 5.640

Review 4.  Advances and Prospects in Vaccine Development against Enterococci.

Authors:  Ermioni Kalfopoulou; Johannes Huebner
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.